European Biostasis Foundation
The European Biostasis Foundation (EBF) is a nonprofit[1] organization dedicated to basic, translational, and applied research in the areas of biostasis, cryobiology, and biopreservation.[2] Founded in 2019, it is based in Basel, Switzerland.[3][2] With its research / long-term care facility in Rafz,[4] close to Zurich, EBF funds, conducts, and coordinates research projects in Switzerland, Europe, and globally.[2] EBF's Chairman of the Board is Emil Kendziorra.[5]
EBF is Tomorrow Biostasis' main partner for long-term cryopreservation.[6] EBF's long-term care facility was completed in 2022. As of January 2025, EBF has 20 cryonics patients.[7]
EBF organized the Biostasis2020 conference in October 2020, the Biostasis2021 conference in October 2021, the Biostasis2022 conference in October 2022, the Biostasis2023 conference in October 2023, and the Biostasis2024 conference in October 2024.
Sources[править]
- ↑ Tomorrow's 2021 - And Outlook For 2022. Emil Kendziorra. tomorrowbiostasis.com. January 21, 2022
- ↑ 2,0 2,1 2,2 Official website
- ↑ One year down, decades to go. Emil Kendziorra. February 3, 2021
- ↑ EBF Facility – The secure location for cutting-edge research and storage. ebf.foundation
- ↑ LinkedIn: Dr. Emil Kendziorra
- ↑ Frequently Asked Questions. tomorrowbiostasis.com
- ↑ Documents and statistics for our patients. tomorrow.bio. Retrieved April 15, 2025
External links[править]
- Official website
- LinkedIn: European Biostasis Foundation
- Facebook page
- Instagram profile
- Twitter profile
- YouTube channel
- YouTube: Storing dead people at -196°C (Tom Scott's visit to the EBF facility)